[PPAR gamma and thiozolidinedione derivatives as an antidiabetic drug for treating insuline resistance].
Horikoshi
H
H
Research Institute, Sankyo Co., Ltd., Tokyo, Japan. hhorikoshi@sankyo-spri.com
Yachi
M
M
D000818:Animals; D002839:Chromans / Q000494:pharmacology; D015195:Drug Design; D006801:Humans; D007004:Hypoglycemic Agents; D007333:Insulin Resistance; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists / Q000502:physiology; D000077154:Rosiglitazone; D013844:Thiazoles / Q000494:pharmacology; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000819:agonists / Q000502:physiology; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; D000077154:Rosiglitazone; D000077288:Troglitazone